Newsroom
Nanopath Announces $25 Million Series B Financing to Advance Molecular Testing for Women’s Health
Nanopath, a Massachusetts-based molecular diagnostics company and recipient of support through multiple Massachusetts Life Sciences Center (MLSC) initiatives, has secured $25 million in Series B financing, including $2 million in…
1 min. read
Just A Start Expands Pathways to Life Sciences Careers Through Pathmaker
Through the Massachusetts Life Sciences Center’s (MLSC) Pathmaker program, Just A Start is expanding access to biotechnology training and creating new pathways for Massachusetts residents to pursue careers in the…
2 min. read
MLSC Support Strengthens Research Capabilities at Brandeis University’s Light Microscopy Core Facility
At Brandeis University in Waltham, investments from the Massachusetts Life Sciences Center (MLSC) are expanding access to advanced imaging technologies that allow researchers to examine biological systems with greater precision…
4 min. read
MLSC’s 2026 MassNextGen Showcase
Today, the Massachusetts Life Sciences Center (MLSC) welcomed investors, stakeholders, and industry leaders to Takeda for the 2026 Massachusetts Next Generation (MassNextGen) Showcase, celebrating underrepresented entrepreneurs and fostering meaningful connections…